For the year ending 2025-12-31, ONC has $8,188,573K in assets. $3,827,379K in debts. $4,547,530K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 4,547,530 | |||
| Accounts receivable, net | 865,080 | |||
| Inventories, net | 608,227 | |||
| Prepaid expenses and other current assets | 212,752 | |||
| Total current assets | 6,233,589 | |||
| Land | 71,434 | |||
| Building | 1,187,836 | |||
| Machinery And Equipment | 273,769 | |||
| Laboratory Equipment | 309,471 | |||
| Software And Software Development Costs | 124,136 | |||
| Leasehold Improvements | 76,568 | |||
| Property and equipment, at cost | 2,043,214 | |||
| Less accumulated depreciation | 528,695 | |||
| Construction in progress | 127,159 | |||
| Property, plant and equipment, net | 1,641,678 | |||
| Operating lease right-of-use assets | 148,184 | |||
| 2026 | 6,293 | |||
| 2027-Cost Of Sales | 6,226 | |||
| 2027-Selling General And Administrative Expenses | 67 | |||
| 2027 | 6,293 | |||
| 2028 | 6,293 | |||
| 2030 | 6,293 | |||
| 2031 and thereafter | 31,239 | |||
| Intangible assets, net | 62,704 | |||
| Other non-current assets | 102,418 | |||
| Total non-current assets | 1,954,984 | |||
| Total assets | 8,188,573 | |||
| Accounts payable | 479,035 | |||
| Accrued expenses and other payables | 1,109,120 | |||
| Tax payable | 41,625 | |||
| Operating lease liabilities, current portion | 20,698 | |||
| Research and development cost share liability, current portion | 64,345 | |||
| Sale of future royalty liability, current portion | 56,714 | |||
| Short-term debt | 57,293 | |||
| Total current liabilities | 1,828,830 | |||
| Long-term debt | 961,913 | |||
| Sale of future royalty liability, non-current portion | 850,242 | |||
| Operating lease liabilities, non-current portion | 52,940 | |||
| Deferred tax liabilities | 53,209 | |||
| Research and development cost share liability, non-current portion | 0 | |||
| Other long-term liabilities | 80,245 | |||
| Total non-current liabilities | 1,998,549 | |||
| Total liabilities | 3,827,379 | |||
| Ordinary shares, 0.0001 par value per share 1,540,975,898 and 1,387,367,704 shares issued and 1,441,075,618 and 1,387,367,704 shares outstanding as of december31,2025 and 2024, respectively | 144 | |||
| Additional paid-in capital | 12,759,137 | |||
| Accumulated other comprehensive loss | -78,184 | |||
| Accumulated deficit | -8,319,903 | |||
| Total shareholders equity | 4,361,194 | |||
| Total liabilities and shareholders equity | 8,188,573 | |||
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC)